Abstract
Although larger trinucleotide expansions give rise to a neurodevelopmental disorder called fragile X syndrome, fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder caused by a “premutation” (55–200 CGG repeats) in the FMR1 gene. FXTAS is one of the more common single-gene forms of late-onset ataxia and tremor that may have a more complex development in women, with atypical presentations. After a brief presentation of the atypical case of an Italian woman with FXTAS, who had several paroxysmal episodes suggestive of acute cerebellar and/or brainstem dysfunction, this article will revise the phenotype of FXTAS in women. Especially in females, FXTAS has a broad spectrum of symptoms, ranging from relatively severe diseases in mid-adulthood to mild cases beginning in later life. Female FXTAS and male FXTAS have a different symptomatic spectrum, and studies on the fragile X premutation should be conducted separately on women or men. Hopefully, a better understanding of the molecular processes involved in the polymorphic features of FXTAS will lead to more specific and effective therapies for this complex disorder.
Highlights
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder caused by a “premutation” (55–200 CGG repeats) in the FMR1 gene at Xq27.3
It has been estimated that about 40% of male and 16% of female carriers develop fragile X-associated tremor/ataxia syndrome (FXTAS)
The phenotypical outcomes of FXTAS require the expression of the abnormal FMR1 messenger RNA (mRNA), but the exact links between mRNA and the clinical features are still unclear [1]
Summary
Daniele Orsucci 1, * , Lucia Lorenzetti 2 , Fulvia Baldinotti 3 , Andrea Rossi 4 , Edoardo Vitolo 2 , Fabio Luigi Gheri 2 , Alessandro Napolitano 5 , Giancarlo Tintori 2 and Marco Vista 1.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have